Response to: "Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions"

J Am Acad Dermatol. 2021 Aug;85(2):e111-e112. doi: 10.1016/j.jaad.2021.04.028. Epub 2021 Apr 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Humans
  • Immune Checkpoint Inhibitors
  • Stevens-Johnson Syndrome* / drug therapy
  • Stevens-Johnson Syndrome* / etiology

Substances

  • Anti-Bacterial Agents
  • Immune Checkpoint Inhibitors